NIH-funded research R01 grant

Repairing blood vessel damage that causes bleeding and clots after severe injury

Official title: Endothelial Dysfunction and Restoration in Trauma Induced Coagulopathy

Funded at University of Pittsburgh at Pittsburgh · NIH-11178361 · Data updated 2026-11-12

This project tests whether signals and plasma treatments can protect and repair the lining of blood vessels to reduce bleeding and dangerous clots in people with severe traumatic injuries.

More Endothelial Dysfunction research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pittsburgh at Pittsburgh
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startSeptember 15, 2023
Project endAugust 31, 2028
Funding year2025
Award (this year)$2,365,012
NIH project number5R01HL166944-03
Project IDNIH-11178361 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are people admitted with severe traumatic injuries who are at risk for trauma-induced coagulopathy and are treated at participating trauma centers.

Less likely to help

People with minor injuries, chronic non-traumatic bleeding disorders, or conditions unrelated to trauma-induced endothelial injury are unlikely to benefit directly from this work.

What this research studies

I would learn how the team looks for molecules in the blood after serious injuries that harm the blood vessel lining and trigger bleeding or clotting problems. They will use a “cue, signal, response” plan to map which circulating factors activate damaging pathways in the endothelium. The researchers will compare samples from trauma patients and build a profile of a healthy “reparative” blood vessel response, including how plasma transfusion changes that response. Findings will help point to new treatments to protect vessels and lower complications after major trauma.

Why it matters

Potential benefit: If successful, this work could lead to treatments that protect and repair the blood vessel lining and lower deaths and complications from trauma-related bleeding and clots.

How similar studies have gone: Earlier trials of early plasma transfusion have shown reduced endothelial injury and improved survival after severe trauma, but the biological mechanisms remain unclear and need further study.

Where this research is happening

  • University of Pittsburgh at Pittsburgh
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Neal, Matthew D — University of Pittsburgh at Pittsburgh
  • Study coordinator: Neal, Matthew D

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.